Synergy Rx Recalls LP Cream Due to Sterility Assurance Issues
Synergy Rx is recalling LP Cream (Lidocaine 15%/Prilocaine 5%) because the product lacks assurance of sterility and has CGMP deviations.
The agency’s classification
FDA (Drugs): Class II
Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.
This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work
What this means for you
Our assessment, not the agency’s: severity 4/5 (Severe).
The hazard poses a serious risk of illness, injury, or structural failure. Stop using the product immediately and contact the manufacturer for a refund or repair.
Our severity reasoning: The agency classification is FDA Class II, and the hazard involves a lack of assurance of sterility in a medical product, which aligns with the 'Severe' criteria for significant risk.
Plain-English summary
Synergy Rx is recalling LP Cream (Lidocaine 15%/Prilocaine 5%), a prescription-only topical medication. The recall is being conducted because the product lacks assurance of sterility and the manufacturer has identified Current Good Manufacturing Practice (CGMP) deviations.
The recall covers all lots of the product. Distribution was nationwide within the United States.
Consumers with this product should stop using it and contact their healthcare provider or the recalling firm for further instructions.
The recalled product
- Product
- LP CREAM (Lidocaine 15%/Prilocaine 5%), Rx only, Synergy RX, 4901 Morena Blvd # 504-A San Diego, CA 92117 (855) 792-6676
- Manufacturer
- Synergy Rx
- Category
- Drug — Topical Anesthetic
- Hazard
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (1)
- All Lots
Distribution
Distributed nationwide across the United States.
Part of a larger recall action
This product is one of 81 recalled by Synergy Rx under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 81 products in this recall →Related recalls
Same manufacturer · Synergy Rx
See all →- SevereSynergy Rx Recalls Lidocaine Creams Due to Sterility Assurance Issues
FDA (Drugs) · 2017-03-22
- HighSynergy Rx Recalls Ultra Lite Cream Due to Sterility Concerns
FDA (Drugs) · 2017-03-22
- SevereSynergy Rx Recalls Lactic Acid Solution Due to Sterility Concerns
FDA (Drugs) · 2017-03-22
- HighSynergy Rx Modified Jessner Peel Recalled for Sterility Assurance Issues
FDA (Drugs) · 2017-03-22
- SevereSynergy Rx Recalls CLEAR 2 Due to Sterility Assurance Concerns
FDA (Drugs) · 2017-03-22
Same hazard · sterility
See all →- SevereK.C. Pharmaceuticals Recalls Target Eye Drops for Sterility Concerns
FDA (Drugs) · 2026-10-14
- SevereFDA Recalls Tri-MIX Injectable Due to Sterility Concerns
FDA (Drugs) · 2026-10-14
- SevereFDA Recalls Semaglutide/Cyanocobalamin Injectable Due to Sterility Concerns
FDA (Drugs) · 2026-10-14
- SevereFDA Recalls Tirzepatide Injectable Due to Sterility Concerns
FDA (Drugs) · 2026-10-14
- SevereK.C. Pharmaceuticals Recalls Leader Advanced Relief Eye Drops for Sterility Concerns
FDA (Drugs) · 2026-10-14
Similar recalls
- ModerateLidocaine-Prilocaine Cream Recalled Due to Incomplete Stability Studies
FDA (Drugs) · 2023-06-07
- ModerateLidocaine Cream 4% Recalled Due to cGMP Deviations
FDA (Drugs) · 2022-03-30
- SevereRXQ Compounding Recalls Lidocaine Syringes Due to Sterility Concerns
FDA (Drugs) · 2019-08-14
- HighFDA Recalls Lidocaine Prilocaine Cream Due to Manufacturing Compliance Issue
FDA (Drugs) · 2022-05-11
- SeverePharmakon Recalls Lidocaine Syringes Due to Sterility Assurance Concerns
FDA (Drugs) · 2016-07-20
- ModerateLidocaine Ointment USP 5% Recalled Due to cGMP Deviations
FDA (Drugs) · 2022-03-30